Current FDA concern The FDA says compounded AOD-9604 may carry immunogenicity risks for some routes and may have problems linked to peptide impurities and product characterization
Contrast that with a patient eating a varied omnivorous diet with no B12 risk factors who receives the same formulation
Vial Format Supplied lyophilized in 5mg, 10mg, and 15mg strengths
However, more important is the practical evidence from a considerable number of the studies, particularly in gastrointestinal research, that intragastric administration or per os administration in drinking water, is equally effective as injections of the supplement administered to rodents, which has been performed in the majority of studies on BPC 157
I used to be a real foody until the gut part of whatever this is began
Its important to get any therapeutic peptide only from qualified medical providers, either in person or via a reputable telehealth service